Los principales fabricantes de antídotos contra el coronavirus, que llegaron a ganar 90.000 millones en 2021 y 2022, exploran ahora alternativas ante la caída de las ventas y los precios de sus princi ...

Several vaccines against Bundibugyo virus are being developed as scientists work to close a gap in Ebola protection. ALSO READ: First human trial begins for Bundibugyo Ebola vaccine The strain is ...

The Government has said it will invest £33.2m in eight projects to tackle overseas disease outbreaks that pose risks to the ...

Day four of the Innovation Festival looked outwards from Manchester to the world. At the inaugural Cambridge x Manchester ...

AstraZeneca (LSE:AZN) slips after Summit Therapeutics investment news and a new Boston site opening; sector context for UK pharma investors.

While levels of flu are currently low, figures from September have been higher than the same period for the last four years ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Guardant360® CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support ...

Deputatii si senatorii dezbat bugetul asigurarilor sociale de stat pentru anul 2021. In Parlament a luat cuvantul si premierul Florin Citu.

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research ...

The Phase I trial is being carried out by the Medical Research Council/Uganda Virus Research Institute and the London School of Hygiene & Tropical.

Dr Koh brings extensive infectious disease and clinical development expertise as RQ Bio prepares to advance RQB01 into the ...